Eko Health received FDA clearance this week for a new AI-powered tool that aids in the early detection of low ejection fraction, a key indicator of heart failure.. About 6.2 million Americans ...

Virtual echocardiography screening tool scores calculated via algorithm matched manually calculated scores and are promising ...

ISSAQUAH, Wash.--(BUSINESS WIRE)--BaroPace Inc. announces its Phase I first-in-human trial of PressurePace TM, its patent-pending pacemaker control algorithm for the treatment of heart failure ...

San Francisco, CA, Dec. 18, 2019 (GLOBE NEWSWIRE) -- Eko, a digital health company applying artificial intelligence (AI) in the fight against heart disease, today announced the U.S. Food and Drug ...

Heart failure affects nearly 6.7 million adults in the U.S., resulting in over $30 billion in annual healthcare costs and nearly 50% of patients being readmitted within six months.

An AI-based algorithm for the detection of heart failure gained FDA clearance. The system is designed to quickly detect low ejection fraction during a routine physical exam.

Belgrade, Serbia – 17 May 2025. An artificial intelligence-enabled electrocardiogram-based algorithm performed well in the early detection of heart failure among healthcare-seeking individuals ...

New AI-powered algorithm could better assess people’s risk of common heart condition Early detection of atrial fibrillation can reduce the risk of stroke and heart failure, but screening people ...

The machine learning algorithm RF-SLAM accurately predicted all-cause mortality and heart failure hospitalization among patients with implantable cardioverter defibrillators.

A Novel Cardiac Scale and Algorithm for Detecting Worsening Congestion Preceding Heart Failure Events (HFEs): A Preliminary Analysis of the SCALE-HF 1 Study. Presenter: Marat Fudim. March 06, 2024.

Non-Invasive Multisensor Algorithm to Predict Worsening Heart Failure by Change in Natriuretic Peptides. Presenter: Andrew Sauer. March 05, 2024. REGISTER for free or LOG IN to view this content.